Wearable cancer device kills lung cancer cells with electrical fields
MedCity News - 16-Oct-2024The technology extends survival for some patients by 3.3 months
Join the club for FREE to access the whole archive and other member benefits.
Treating solid tumor cancers
Novocure's logo represents a global company pioneering Tumor Treating Fields (TTFields) therapy, an innovative cancer treatment that uses electric fields to target and kill cancer cells. This therapy is designed to complement traditional cancer treatments, providing a new, versatile option for solid tumor treatment. Research shows TTFields therapy can be used in combination with other cancer therapies, enhancing its effectiveness. Novocure's ongoing clinical trials and preclinical research explore its potential across various tumor types. Novocure also provides resources for patients and healthcare professionals, offering educational materials on TTFields therapy and its mechanisms.
Visit website: https://www.novocure.com/
Details last updated 17-Oct-2024
The technology extends survival for some patients by 3.3 months
This expansion follows earlier FDA approval in the U.S. With financing from JPMorgan